Silvana F Marasco, Janelle McLean, Christina E Kure, Julia Rix, Tanieka Lake, Ashlee Linton, James Farag, Michael Z L Zhu, Atsuo Doi, Peter J Bergin, Angeline S Leet, Andrew J Taylor, James L Hare, Hitesh C Patel, David Kaye, David C McGiffin
OBJECTIVES: Right ventricular failure following implantation of a durable left ventricular assist device (LVAD) is a major driver of mortality. Reported survival following biventricular (BiVAD) or total artificial heart (TAH) implantation remains substantially inferior to LVAD alone. We report our outcomes with LVAD and BiVAD HeartMate 3 (HM3). METHODS: Consecutive patients undergoing implantation of an HM3 LVAD between November 2014 and December 2021, at The Alfred, Australia were included in the study...
March 8, 2024: Artificial Organs